This is in contrast to a previous, smaller study (n = 248) in the American population, which suggested that tumor p53 status was associated with breast cancer survival only among patients homozygous for the MDM2 SNP309 T-allele and not among carriers of the variant G-allele [22]. The gene discussed is TP53; the disease is breast carcinoma.